UB Paderborn / Katalog / Suche / in CDI

The P2X7 Receptor: A Key Player in IL-1 Processing and Release

The Journal of immunology (1950), 2006-04, Vol.176 (7), p.3877-3883

2006

Volltextzugriff (PDF)

Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications

Immunology letters, 2004-06, Vol.94 (1), p.11-26

2004

Volltextzugriff (PDF)

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6

Blood, 2002-07, Vol.100 (1), p.230-237

2002

Volltextzugriff (PDF)

Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function

Journal of translational medicine, 2019-08, Vol.17 (1), p.250-14, Article 250

2019

Volltextzugriff (PDF)

Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)

Leukemia & lymphoma, 2016-06, Vol.57 (6), p.1256-1268

2016

Volltextzugriff (PDF)

Extracellular nucleotides are potent stimulators of human hematopoietic stem cells in vitro and in vivo

Blood, 2004-09, Vol.104 (6), p.1662-1670

2004

Volltextzugriff (PDF)

Granulocyte colony‐stimulating factor promotes the generation of regulatory DC through induction of IL‐10 and IFN‐α

European journal of immunology, 2004-05, Vol.34 (5), p.1291-1302

2004

Volltextzugriff (PDF)

Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients

Haematologica (Roma), 2005-02, Vol.90 (2), p.225-231

2005

Volltextzugriff (PDF)

Molecular Remission After Allogeneic or Autologous Transplantation of Hematopoietic Stem Cells for Multiple Myeloma

Journal of clinical oncology, 2000-06, Vol.18 (11), p.2273-2281

2000

Volltextzugriff (PDF)

Interleukin-11 induces Th2 polarization of human CD4+ T cells

Blood, 2001-05, Vol.97 (9), p.2758-2763

2001

Volltextzugriff (PDF)

High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma

Bone marrow transplantation (Basingstoke), 1998-07, Vol.22 (1), p.27-32

1998

Volltextzugriff (PDF)

Stem Cell Factor and FLT3-Ligand Are Strictly Required to Sustain the Long-Term Expansion of Primitive CD34+DR- Dendritic Cell Precursors

The Journal of immunology (1950), 2001-01, Vol.166 (2), p.848-854

2001

Volltextzugriff (PDF)

In vitro anti‐tumour activity of anti‐CD80 and anti‐CD86 immunotoxins containing type 1 ribosome‐inactivating proteins

British journal of haematology, 2000-08, Vol.110 (2), p.351-361

2000

Volltextzugriff (PDF)

Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patients

Haematologica (Roma), 2001-05, Vol.86 (5), p.504

2001

Volltextzugriff (PDF)

Cell therapy: achievements and perspectives

Haematologica (Roma), 1999-12, Vol.84 (12), p.1110

1999

Volltextzugriff (PDF)

The Kinetic Status of Hematopoietic Stem Cell Subpopulations Underlies a Differential Expression of Genes Involved in Self‐Renewal, Commitment, and Engraftment

Stem cells (Dayton, Ohio), 2005-04, Vol.23 (4), p.496-506

2005

Volltextzugriff (PDF)

Concomitant Mobilization of Plasma Cells and Hematopoietic Progenitors Into Peripheral Blood of Multiple Myeloma Patients: Positive Selection and Transplantation of Enriched CD34+ Cells to Remove Circulating Tumor Cells

Blood, 1996-02, Vol.87 (4), p.1625-1634

1996

Volltextzugriff (PDF)

Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells

Experimental hematology, 2005-12, Vol.33 (12), p.1521-1530

2005

Volltextzugriff (PDF)

Generation of dendritic cells from CD14+ monocytes positively selected by immunomagnetic adsorption for multiple myeloma patients enrolled in a clinical trial of anti‐idiotype vaccination

British journal of haematology, 2003-04, Vol.121 (2), p.240-250

2003

Volltextzugriff (PDF)

Stem cell plasticity: time for a reappraisal?

Haematologica (Roma), 2005-03, Vol.90 (3), p.360-381

2005

Volltextzugriff (PDF)

Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma

Blood, 2000-07, Vol.96 (1), p.355-357

2000

Volltextzugriff (PDF)

Autologous transplantation of granulocyte colony-stimulating factor–primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilization

Blood, 2003-09, Vol.102 (5), p.1595-1600

2003

Volltextzugriff (PDF)

Impaired dendritic cell immunophenotype and function in heart transplant patients undergoing active cytomegalovirus infection

Transplantation, 2005-01, Vol.79 (2), p.219

2005

Volltextzugriff (PDF)

Antitumor vaccination: where we stand

Haematologica (Roma), 2000-11, Vol.85 (11), p.1172

2000

Volltextzugriff (PDF)

Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor

Blood, 1997-02, Vol.89 (4), p.1189-1196

1997

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

The P2X7 Receptor: A Key Player in IL-1 Processing and Release

Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6

Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function

Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)

Extracellular nucleotides are potent stimulators of human hematopoietic stem cells in vitro and in vivo

Granulocyte colony‐stimulating factor promotes the generation of regulatory DC through induction of IL‐10 and IFN‐α

Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients

Molecular Remission After Allogeneic or Autologous Transplantation of Hematopoietic Stem Cells for Multiple Myeloma

Interleukin-11 induces Th2 polarization of human CD4+ T cells

High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma

Stem Cell Factor and FLT3-Ligand Are Strictly Required to Sustain the Long-Term Expansion of Primitive CD34+DR- Dendritic Cell Precursors

In vitro anti‐tumour activity of anti‐CD80 and anti‐CD86 immunotoxins containing type 1 ribosome‐inactivating proteins

Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patients

Cell therapy: achievements and perspectives

The Kinetic Status of Hematopoietic Stem Cell Subpopulations Underlies a Differential Expression of Genes Involved in Self‐Renewal, Commitment, and Engraftment

Concomitant Mobilization of Plasma Cells and Hematopoietic Progenitors Into Peripheral Blood of Multiple Myeloma Patients: Positive Selection and Transplantation of Enriched CD34+ Cells to Remove Circulating Tumor Cells

Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells

Generation of dendritic cells from CD14+ monocytes positively selected by immunomagnetic adsorption for multiple myeloma patients enrolled in a clinical trial of anti‐idiotype vaccination

Stem cell plasticity: time for a reappraisal?

Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma

Autologous transplantation of granulocyte colony-stimulating factor–primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilization

Impaired dendritic cell immunophenotype and function in heart transplant patients undergoing active cytomegalovirus infection

Antitumor vaccination: where we stand

Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor

Suchergebnisse filtern